IL17A and neoplasm: Studies have revealed that IL-17 is intricately involved in the tumor’s pathophysiology, influencing processes such as tumorigenesis, proliferation, angiogenesis, and metastasis, as well as enabling the tumor to develop resistance to both immune responses and chemotherapy.28